Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

El Pais

Lean Left

Factuality

Ownership

Their actions react with increases to the new commercial impulse

Bioethics.com

Factuality

Ownership

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

(New York Times) – Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible. Novo Nordisk will cut the price of its blockbuster weight loss medication Wegovy to $499 per month for certain patients who pay using their own money instead of going through insurance, the drug maker said on Wednesday. (Read More)

CDR – Chain Drug Review

Factuality

Ownership

Novo Nordisk introduces NovoCare Pharmacy, lowering cost of all doses of approved Wegovy

PLAINSBORO, N.J. – As part of its ongoing efforts to ensure patients who need Wegovy (semaglutide) injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg can access it, Novo Nordisk launched NovoCare Pharmacy, a direct-to-patient delivery option that offers cash-paying patients all dose strengths of Wegovy at a reduced cost of $499 per month. This offer is available for uninsured patients or eligible patients with commercial insurance who do not ha…